Company profile for Cell Therapies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established in 2003, Cell Therapies Pty Ltd (CTPL) is one of the most experienced cGMP compliant manufacturers for cell therapies, gene therapies, cellular immunotherapies and regenerative medicine products globally. CTPL offers: Contract Development and Manufacturing (CDMO) of cell-based therapies to meet global regulatory requirements for clinical trials and commercial supply Apheresis collection protocol development, c...
Established in 2003, Cell Therapies Pty Ltd (CTPL) is one of the most experienced cGMP compliant manufacturers for cell therapies, gene therapies, cellular immunotherapies and regenerative medicine products globally. CTPL offers: Contract Development and Manufacturing (CDMO) of cell-based therapies to meet global regulatory requirements for clinical trials and commercial supply Apheresis collection protocol development, collection site assessment and establishment, and collection network management Clinical trial support, including assistance with clinical trial design, protocol development, regulatory submission etc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Victorian Comprehensive Cancer Centre Level 9, 305 Grattan Street Melbourne VI...
Telephone
Telephone
+61 3 8559 7310
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/06/06/3095096/0/en/Nkarta-Appoints-Shawn-Rose-Chief-Medical-Officer-Head-of-R-D-as-Company-Resets-Senior-Leadership-Role-for-Autoimmune-Focus.html

GLOBENEWSWIRE
06 Jun 2025

https://www.globenewswire.com/news-release/2025/03/25/3049068/0/en/Tevogen-Bio-Appoints-David-E-Banko-as-Global-Head-of-Government-Affairs-and-Patient-Access-Advances-Commercialization-Plan.html

GLOBENEWSWIRE
25 Mar 2025

https://www.globenewswire.com//news-release/2025/03/04/3036422/0/en/FluidForm-Bio-Announces-Co-Founder-and-CTO-Adam-Feinberg-PhD-to-Participate-in-the-2025-SXSW-Conference-Exhibits.html

GLOBENEWSWIRE
04 Mar 2025

https://www.businesswire.com/news/home/20250108335836/en

BUSINESSWIRE
08 Jan 2025

https://www.globenewswire.com/news-release/2025/01/08/3006688/0/en/FluidForm-Bio-Announces-Participation-at-Biotech-Showcase-and-the-14th-Annual-LifeSci-Partners-Corporate-Access-Event.html

GLOBENEWSWIRE
08 Jan 2025

https://www.globenewswire.com/news-release/2024/11/05/2974972/0/en/Tessera-Therapeutics-to-Present-New-Preclinical-Data-From-In-Vivo-Programs-for-Sickle-Cell-Disease-and-T-Cell-Therapies-at-the-66th-American-Society-of-Hematology-Annual-Meeting.html

GLOBENEWSWIRE
05 Nov 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty